Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy
NCT06062030Phase 3Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Mar 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of DWJ1609 in bowel preparation (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoint: Successful cleaning rate of the Harefield Cleansing Scale (HCS). Started Mar 2024; status: completed.
02
Drugs
DWJ1609
03
Conditions
bowel preparation
Beyond the preview
Go deeper on NCT06062030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06062030.